Literature DB >> 11970783

fMRI study of cognitive interference processing in females with fragile X syndrome.

Leanne Tamm1, Vinod Menon, Cindy K Johnston, David R Hessl, Allan L Reiss.   

Abstract

Females with fragile X syndrome, the most common form of inherited developmental and learning problems, are known to be impaired in executive function. The current study is the first to investigate the performance of females with fragile X on a cognitive interference task utilizing functional magnetic resonance imaging (fMRI). Fourteen females with fragile X and 14 age-matched healthy controls were imaged while they performed a counting Stroop interference task. Compared to controls, females with fragile X appeared to have longer reaction times during the interference condition of the task, and adopted a strategy trading speed for accuracy. Females with fragile X also had a significantly different pattern of activation than controls. Whereas controls showed significant activation in the inferior/middle frontal gyrus and inferior/superior parietal lobe, females with fragile X showed more extensive activation in the anterior region of the prefrontal cortex, and failed to show expected activation in the inferior/superior parietal lobe. Further, between-group analyses revealed that females with fragile X had reduced activation in the left orbitofrontal gyrus, thought to be involved in modulating goal-directed behavior. Females with fragile X also demonstrated a markedly different pattern of deactivation from controls. These findings suggest that deficits in cognitive interference processing during the counting Stroop task observed in females with fragile X may arise from inability to appropriately recruit and modulate lateral prefrontal and parietal resources.

Entities:  

Mesh:

Year:  2002        PMID: 11970783     DOI: 10.1162/089892902317236812

Source DB:  PubMed          Journal:  J Cogn Neurosci        ISSN: 0898-929X            Impact factor:   3.225


  21 in total

1.  Discrimination learning and attentional set formation in a mouse model of Fragile X.

Authors:  Kimberly S Casten; Annette C Gray; Rebecca D Burwell
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 2.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

3.  Graphical-model-based multivariate analysis of functional magnetic-resonance data.

Authors:  Rong Chen; Edward H Herskovits
Journal:  Neuroimage       Date:  2007-01-25       Impact factor: 6.556

4.  Arousal modulation in females with fragile X or Turner syndrome.

Authors:  Jane Roberts; Michèle M M Mazzocco; Melissa M Murphy; Rudolf Hoehn-Saric
Journal:  J Autism Dev Disord       Date:  2007-03-06

5.  Emotion recognition and visual-scan paths in Fragile X syndrome.

Authors:  Tracey A Shaw; Melanie A Porter
Journal:  J Autism Dev Disord       Date:  2013-05

Review 6.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

7.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

Review 8.  Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies.

Authors:  Amy A Lightbody; Allan L Reiss
Journal:  Dev Disabil Res Rev       Date:  2009

Review 9.  Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.

Authors:  John A Tsiouris; W Ted Brown
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Delineation of early attentional control difficulties in fragile X syndrome: focus on neurocomputational changes.

Authors:  Gaia Scerif; Kim Cornish; John Wilding; Jon Driver; Annette Karmiloff-Smith
Journal:  Neuropsychologia       Date:  2007-01-24       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.